Navigation Links
Actos Lawyers at Bernstein Liebhard LLP Comment on California Judge’s Decision to Set Aside Verdict in Nation’s First Actos Bladder Cancer Trial
Date:5/3/2013

New York, New York (PRWEB) May 03, 2013

The Actos lawyers at Bernstein Liebhard LLP note that a California Superior Court judge has set aside a $6.5 million verdict handed down last week in the nation’s first Actos bladder cancer trial. According to a May 3rd Reuters report, in granting Takeda Pharmaceuticals' request to nullify the verdict, Judge Kenneth Freeman of Los Angeles Superior Court asserted that the Plaintiff’s medical expert had failed to establish that Actos was the specific cause of Cooper's bladder cancer.* (Cooper v. Takeda Pharmaceuticals America Inc., CGC-12-518535, California Superior Court)

“We are obviously disappointed with this turn of events, but we are still heartened that the first jury to hear an Actos claim found for the plaintiff. We remain optimistic that future Actos bladder cancer lawsuits will yield victories for plaintiffs,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free Actos lawsuit evaluations to long-term users of the medication who have been diagnosed with bladder cancer.

Actos Bladder Cancer Lawsuits
Court records indicate that Takeda has been named in more than 3,000 Actos bladder cancer lawsuits. Some 1,200 of those Actos lawsuits have been filed in a multidistrict litigation underway in U.S. District Court, Western District of Louisiana. The first trial in that litigation is expected to begin next January. (In re: Actos Product Liability Litigation, MDL No. 2299) All of the Actos lawsuits allege Takeda knew that Actos could increase the risk of bladder cancer in patients taking the drug, but failed to provide adequate warnings about this increased risk.

According to court documents, the Plaintiff in the Los Angeles
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. DrugRisks Legal Update: Jury to Decide Actos Cancer Trial This Week
2. Chaffin Luhana Alerts Actos Patients to Updated MDL Trial Dates
3. DrugRisks Update: Doctor Testifies Actos Main Cause of Bladder Cancer in Trial
4. 2013 Actos Bladder Cancer Claims Now Being Investigated by Resource4thePeople Attorneys
5. DrugRisk Center Adds Latest on First of 3,000 Actos Bladder Cancer Trials
6. DrugRisks Adds Update from First Actos Trial of Patient Alleging Bladder Cancer
7. Drug Safety Center Update: Employee Alleges Actos Maker Valued Sales Over Safety
8. DrugRisk Update: Evidence Submitted in Actos Lawsuit Suggests Drug Maker Knew of Cancer Risks
9. Actos Lawsuit News: Bernstein Liebhard LLP Notes Latest Scheduling Order in Actos Bladder Cancer Litigation
10. US Drug Watchdog Now Urges All Diabetics Nationwide Who Used the Diabetes Drug Actos and now have Bladder Cancer to Call The Johnson Law Group For A Legal Evaluation
11. US Drug Watchdog Now Urges Diabetics Who Used the Diabetes Drug Actos and Then Developed Bladder Cancer to Call the Johnson Law Group for a Legal Review - Get Compensated
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... CO (PRWEB) July 24, 2014 This year ... by E Light Electric and Jackson National Life, will be ... begins at 7 am, the Kids Fun Run at 7:50 ... Walk starts at 9 a.m. , “The Walk to End ... strength and dedication in the fight against this devastating disease, ...
(Date:7/24/2014)... like a medical device or surgical implant is put ... to Northwestern University,s Guillermo Ameer, most of the time, ... function. , "You will always get an inflammatory response ... in Northwestern,s McCormick School of Engineering and Applied Science ... Medicine. "A problem with commonly used plastic materials, in ...
(Date:7/24/2014)... Children,s Hospital and the University of Tennessee Health Science ... new drug shown to safely reduce the viral load ... with respiratory syncytial virus (RSV). RSV is the most ... children in the United States and worldwide. , ... Specialist John DeVincenzo, MD. DeVincenzo,s Le Bonheur lab has ...
(Date:7/24/2014)... Atlanta, GA (PRWEB) July 24, 2014 ... Act on Tuesday, President Obama cited the Atlanta ... 35 model programs from across the country ( ... training as an essential pillar of U.S. economic ... replicated nationally. , “This recognition from President Obama ...
(Date:7/24/2014)... scientists at Carnegie Mellon University, working with high-throughput ... Berkeley National Laboratory, have devised a computational method ... normal breast cells turn malignant and as they ... for analyzing how genes interact with each other ... published today by the online journal PLOS ...
Breaking Medicine News(10 mins):Health News:Alzheimer's Association Walk to End Alzheimer's Steps Off Saturday, September 20 in Denver 2Health News:Alzheimer's Association Walk to End Alzheimer's Steps Off Saturday, September 20 in Denver 3Health News:Antioxidant biomaterial promotes healing 2Health News:RSV research breakthrough to help infected children 2Health News:President Cites Atlanta BeltLine Workforce Partnership in Healthcare as National Model 2Health News:President Cites Atlanta BeltLine Workforce Partnership in Healthcare as National Model 3Health News:President Cites Atlanta BeltLine Workforce Partnership in Healthcare as National Model 4Health News:President Cites Atlanta BeltLine Workforce Partnership in Healthcare as National Model 5Health News:Gene changes in breast cancer cells pinpointed with new computational method 2Health News:Gene changes in breast cancer cells pinpointed with new computational method 3
... Reporter , MONDAY, Sept. 27 (HealthDay News) -- There ... other noncarbonated beverages are associated with physical activity they ... In a study of more than 15,000 middle and ... who drank sugar-sweetened beverages, including sports drinks, were more ...
... Nearly 500 researchers, clinicians and mental health advocates ... Conference, Perinatal Mental Health Research: Harvesting the Potential, Oct. ... in Pittsburgh. The event, which focuses on women,s mental ... former First Lady Rosalynn Carter, who has been an ...
... Reinberg HealthDay Reporter , SATURDAY, Sept. 25 ... not drinking as much water as they should, and ... suggests. "Even mild dehydration can affect physiological function, ... said Samantha Heller, clinical nutrition coordinator at the Center ...
... to arrest the growth and spread of tumors, there have ... internal instruction manual. In a new study, a team ... molecule able to prevent cancer genes from "hearing" those instructions, ... published online by the journal Nature , demonstrates that ...
... Steven Reinberg HealthDay Reporter , THURSDAY, Sept. ... about heart risks, U.S. health officials on Thursday severely ... patients with type 2 diabetes who cannot control their ... Administration officials also ordered the drug,s manufacturer, GlaxoSmithKline, to ...
... and GLG Pharma, LLC announced today that they have ... LLC has acquired the exclusive worldwide rights to a ... Researchers at Moffitt discovered several classes of STAT3 ... drugs. "Persistently activated STAT3 is a major ...
Cached Medicine News:Health News:Study Finds Teens Think Sports Drinks Are Healthy 2Health News:Study Finds Teens Think Sports Drinks Are Healthy 3Health News:U.S. Kids Drink Too Little Water: Study 2Health News:U.S. Kids Drink Too Little Water: Study 3Health News:Researchers create first molecule blocks key component of cancer genes' on-off switch 2Health News:Researchers create first molecule blocks key component of cancer genes' on-off switch 3Health News:FDA Restricts Access to Avandia 2Health News:FDA Restricts Access to Avandia 3
(Date:7/24/2014)... July 24, 2014 Consolidated Net Profit increased ... Highlights   , India Business grew by 20.87% ... to Rs. 4,886.70 Mn Rest of World (ROW) Business ... Business grew by 34.53% to Rs. 977.26 Mn Latin ... Glenmark Pharmaceuticals Limited, the research-led global integrated pharmaceutical ...
(Date:7/24/2014)... , July 24, 2014 /PRNewswire-iReach/ -- Delivery ... once order is placed. Photo - ... a professional and in-depth market survey on Global ... reviews the basic information of Hemodialysis Machine including ... then explores global and China,s top manufacturers of ...
(Date:7/24/2014)... Scotland , July 24, 2014 Cancer patients ... gain access to state-of-the-art cancer treatment closer to home when ... next year. Varian Medical Systems (NYSE: VAR ... an order was placed in June for four TrueBeam™ medical ... systems, which offer fast and efficient radiotherapy and radiosurgery treatments, ...
Breaking Medicine Technology:Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 2Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 3Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 4Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 2Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 3Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 4Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 5Varian Medical Systems Selected to Equip First Satellite Radiotherapy Center in Scotland 2Varian Medical Systems Selected to Equip First Satellite Radiotherapy Center in Scotland 3
... Incorporated (Nasdaq: ARAY ), the premier radiation oncology ... Euan S. Thomson, Ph.D., is scheduled to present at the ... City on Tuesday November 15, 2011 at 10:30 a.m. EST/7:30 ... the Stephens Fall Investment Conference in New York City on ...
... PARSIPPANY, N.J., Nov. 10, 2011 Columbia Laboratories, Inc. ... (NYSE: WPI ), today confirmed that the ... Food and Drug Administration (FDA) is scheduled to review ... for the reduction of risk of preterm birth in ...
Cached Medicine Technology:Columbia Laboratories and Watson Pharmaceuticals Confirm FDA Advisory Committee to Review Preterm Birth NDA 2Columbia Laboratories and Watson Pharmaceuticals Confirm FDA Advisory Committee to Review Preterm Birth NDA 3Columbia Laboratories and Watson Pharmaceuticals Confirm FDA Advisory Committee to Review Preterm Birth NDA 4
The Tag-It™ Cystic Fibrosis ASR reagents can be used by high complexity CLIA approved laboratories for detection of up to 70 mutations and 6 variants (polymorphisms) in the cystic fibrosis tran...
... glucose monitor elevates bedside glucose testing to ... approaches the quality of central laboratory testing. ... measuring strip technology. Current glucose strips ... Multi-Well system measures and corrects hematocrit interference ...
The Tag-It™ Cystic Fibrosis ASR reagents can be used by high complexity CLIA approved laboratories for detection of up to 70 mutations and 6 variants (polymorphisms) in the cystic fibrosis tran...
... The BreatheX is a wearable CPAP ... treatment of sleep apnea. The lightweight BreatheX ... of therapy with its built-in, rechargeable battery, ... users will no longer need to be ...
Medicine Products: